Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT(2)R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies

BACKGROUND: The clinical efficacy of the Angiotensin II (AngII) receptor AT(2)R antagonist EMA401, a novel peripherally-restricted analgesic, was reported recently in post-herpetic neuralgia. While previous studies have shown that AT(2)R is expressed by nociceptors in human DRG (hDRG), and that EMA4...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mol Pain
Hauptverfasser: Anand, Uma, Yiangou, Yiangos, Sinisi, Marco, Fox, Michael, MacQuillan, Anthony, Quick, Tom, Korchev, Yuri E, Bountra, Chas, McCarthy, Tom, Anand, Praveen
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2015
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4482278/
https://ncbi.nlm.nih.gov/pubmed/26111701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12990-015-0038-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge